Sotorasib in KRAS p.G12C-Mutated Pulmonary Sarcomatoid Carcinoma: Therapeutic Efficacy of a KRAS Inhibitor in Symptomatic Brain Metastases
Introduction: Pulmonary sarcomatoid carcinomas (PSCs) are a rare subgroup of non-small cell lung cancer (NSCLC). In contrast to other NSCLCs, PSCs have a poor prognosis due to limited efficacy of radiation and chemotherapy. Therefore, other therapeutic approaches are needed. KRAS mutations occur in...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Karger Publishers
2024-09-01
|
| Col·lecció: | Case Reports in Oncology |
| Matèries: | |
| Accés en línia: | https://beta.karger.com/Article/FullText/540675 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|